BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.0520
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
BetterLife Pharma Market Cap
BetterLife Pharma has a market cap or net worth of $8.01 million as of April 16, 2026. Its market cap has decreased by -27.01% in one year.
Market Cap
8.01M
Enterprise Value
10.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since October 4, 2010, BetterLife Pharma's market cap has decreased from 98.33M to 8.01M, a decrease of -91.85%. That is a compound annual growth rate of -14.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 8.01M | 63.27% |
| Dec 31, 2025 | 4.91M | -47.43% |
| Dec 31, 2024 | 9.33M | 68.00% |
| Dec 29, 2023 | 5.55M | -49.28% |
| Dec 30, 2022 | 10.95M | -24.42% |
| Dec 31, 2021 | 14.49M | -81.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 9.61M |
| ZIVO Bioscience | 8.92M |
| HST Global | 8.91M |
| Curative Biotechnology | 8.37M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.46M |
| TRON Group | 6.68M |
| Galera Therapeutics | 6.50M |